Researchers found that the compound, called cannabidiol, had the ability to 'switch off' the gene responsible for metastasis in an aggressive form of breast cancer. Importantly, this substance does not produce the psychoactive properties of the cannabis plant.
Last year they published a study that found a similar effect in mice. Now they say they are on the verge of publishing further animal study results that expand these results further.
Speaking to the San Francisco Chronicle, study co-leader Dr Sean McAllister, said: 'The preclinical trial data is very strong, and there's no toxicity. There's really a lot or research to move ahead with and to get people excited.'
Eileen Schoch traveled to her mother's funeral in Asheville, N.C. and found the hotel room —...
Dr. Kade Goepferd watched the Trump administration's moves on Thursday to ban gender-affirming care for transgender...
US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss...
With subsidies for Affordable Care Act (ACA) health insurance set to expire, Americans who rely on...
